208 related articles for article (PubMed ID: 7488459)
1. Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease.
de Belder AJ; Radomski MW; Why HJ; Richardson PJ; Martin JF
Br Heart J; 1995 Oct; 74(4):426-30. PubMed ID: 7488459
[TBL] [Abstract][Full Text] [Related]
2. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli A; Barbarini G
Circulation; 1999 Aug; 100(9):933-9. PubMed ID: 10468523
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
Vejlstrup NG; Bouloumie A; Boesgaard S; Andersen CB; Nielsen-Kudsk JE; Mortensen SA; Kent JD; Harrison DG; Busse R; Aldershvile J
J Mol Cell Cardiol; 1998 Jun; 30(6):1215-23. PubMed ID: 9689595
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy.
Habib FM; Springall DR; Davies GJ; Oakley CM; Yacoub MH; Polak JM
Lancet; 1996 Apr; 347(9009):1151-5. PubMed ID: 8609750
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli AM; D'Amati G; Barbarini G;
AIDS; 2000 May; 14(7):827-38. PubMed ID: 10839591
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+) /calmodulin-dependent protein kinase II equally induces sarcoplasmic reticulum Ca(2+) leak in human ischaemic and dilated cardiomyopathy.
Fischer TH; Eiringhaus J; Dybkova N; Förster A; Herting J; Kleinwächter A; Ljubojevic S; Schmitto JD; Streckfuß-Bömeke K; Renner A; Gummert J; Hasenfuss G; Maier LS; Sossalla S
Eur J Heart Fail; 2014 Dec; 16(12):1292-300. PubMed ID: 25201344
[TBL] [Abstract][Full Text] [Related]
9. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.
Funakoshi H; Kubota T; Machida Y; Kawamura N; Feldman AM; Tsutsui H; Shimokawa H; Takeshita A
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2159-66. PubMed ID: 12003824
[TBL] [Abstract][Full Text] [Related]
10. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.
Heymes C; Vanderheyden M; Bronzwaer JG; Shah AM; Paulus WJ
Circulation; 1999 Jun; 99(23):3009-16. PubMed ID: 10368118
[TBL] [Abstract][Full Text] [Related]
11. Expression of inducible nitric oxide synthase in failing and non-failing human heart.
Thoenes M; Förstermann U; Tracey WR; Bleese NM; Nüssler AK; Scholz H; Stein B
J Mol Cell Cardiol; 1996 Jan; 28(1):165-9. PubMed ID: 8745224
[TBL] [Abstract][Full Text] [Related]
12. An association between microvascular endothelial dysfunction, transcardiac nitric oxide production and pro-inflammatory cytokines after heart transplantation in humans.
Wildhirt SM; Weis M; Schulze C; Conrad N; Rieder G; Enders G; Hoepp C; von Scheidt W; Reichart B
Transpl Int; 2000; 13 Suppl 1():S228-34. PubMed ID: 11112001
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase activities in human myocardium.
de Belder AJ; Radomski MW; Why HJ; Richardson PJ; Bucknall CA; Salas E; Martin JF; Moncada S
Lancet; 1993 Jan; 341(8837):84-5. PubMed ID: 7678120
[TBL] [Abstract][Full Text] [Related]
14. Suppressed expression of GTP cyclohydrolase I mRNA and accelerated expression of inducible nitric oxide synthase mRNA in endomyocardial biopsy specimens from patients with dilated cardiomyopathy.
Ohtsuki M; Nomura T; Morimoto S; Hiramitsu S; Uemura A; Kato S; Kato Y; Shiraishi H; Shimokubo J; Yamamoto N; Hishida H
Clin Chim Acta; 2005 Mar; 353(1-2):103-7. PubMed ID: 15698596
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
16. [Multislice spiral computed tomography of the heart in dilated cardiomyopathy: possibilities in the verification of myocarditis (in comparison with myocardial biopsy) and in the evaluation of prognosis].
Alieva IN; Blagova OV; Gagarina NV; Nedostup AV; Kogan EA; Sedov VP; Kadochnikova VV; Donnikov AE; Zaidenov VA; Kupriyanova AG; Ternovoy SK
Ter Arkh; 2017; 89(12):15-27. PubMed ID: 29411756
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide in the regulation of myocardial function.
Hare JM; Colucci WS
Prog Cardiovasc Dis; 1995; 38(2):155-66. PubMed ID: 7568904
[TBL] [Abstract][Full Text] [Related]
18. [Cardiopulmonary exercise testing and cytokines in chronic heart failure. Comparison of patients with ischaemic and with dilated cardiomyopathy].
Straburzyńska-Migaj E; Leśniewska K; Ochotny R; Straburyńska-Lupa A; Baszko A; Wiktorowicz K; Cieśliński A
Pol Arch Med Wewn; 2004 Jun; 111(6):693-701. PubMed ID: 15508792
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy.
Fukuchi M; Hussain SN; Giaid A
Circulation; 1998 Jul; 98(2):132-9. PubMed ID: 9679719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
